Patient Guide: A Study of the Combination of Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for the First-line Treatment of Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 87 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT03462719
Status: ACTIVE_NOT_RECRUITING
Condition: Leukemia, Lymphocytic, Chronic, B-Cell
Phase: PHASE3

Find a Study Location Near You

This study is available at 87 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Louisville, Kentucky
  • • Hackensack, New Jersey
  • • Charlotte, North Carolina
  • • And 84 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of the Combination of Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for the First-line Treatment of Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) - Join Clinical Trial NCTNCT03462719

How to Join This Clinical Trial - NCTNCT03462719

Learn how to participate in this PHASE3 trial studying an investigational therapy for Leukemia, Lymphocytic, Chronic, B-Cell. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Leukemia, Lymphocytic, Chronic, B-Cell. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Leukemia, Lymphocytic, Chronic, B-Cell
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT03462719 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 87 locations. Find a study site near you:

Clinical Research Site

Louisville, Kentucky 40207 - United States

Status: Contact for availability

Clinical Research Site

Hackensack, New Jersey 07601 - United States

Status: Contact for availability

Clinical Research Site

Charlotte, North Carolina 28204 - United States

Status: Contact for availability

Clinical Research Site

Anderlecht, 1070 - Belgium

Status: Contact for availability

Clinical Research Site

Antwerp, 2060 - Belgium

Status: Contact for availability

Clinical Research Site

Ghent, 9000 - Belgium

Status: Contact for availability

Clinical Research Site

Hasselt, 3500 - Belgium

Status: Contact for availability

Clinical Research Site

Leuven, 3000 - Belgium

Status: Contact for availability

Clinical Research Site

Calgary, Alberta T2N 5G2 - Canada

Status: Contact for availability

Clinical Research Site

Edmonton, Alberta T6G 1Z2 - Canada

Status: Contact for availability

And 77 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Leukemia, Lymphocytic, Chronic, B-Cell:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation